Vericel Corporation VCEL
54.62 USD +2.84 (+5.48%)
At closeNov 6, 2026, 6:55 PM EST
56.32 +1.70 +3.11%
After hours · Nov 6, 6:55 PM ET
50.76 Day range 54.64
29.34 52-week range 54.62
- YTD
- +51.68%
- 1 year
- +40.95%
News
seekingalpha.com Vericel Corporation (VCEL) Q3 2026 Earnings Call Transcript Vericel Corporation ( VCEL ) Q3 2026 Earnings Call November 5, 2026 8:30 AM EST Company Participants Eric Burns - Vice President of Finance & Investor Relations Dominick C. Colangelo - CEO, President…
benzinga.com HC Wainwright & Co. Maintains Buy on Vericel, Raises Price Target to $75 HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Vericel (NASDAQ:VCEL) with a Buy and raises the price target from $72 to $75.
defenseworld.net Vericel (NASDAQ:VCEL) Hits New 12-Month High on Strong Earnings Vericel Corporation (NASDAQ: VCEL - Get Free Report)'s stock price hit a new 52-week high during trading on Thursday after the company announced better than expected quarterly earnings. The company…
zacks.com Vericel Corporation (VCEL) Beats Q3 Earnings and Revenue Estimates Vericel Corporation (VCEL) came out with quarterly earnings of $0.27 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.1 per share a year ago.
benzinga.com Motorola Solutions, Sezzle, Unity Software, Toyota Motor And Other Big Stocks Moving Higher On Thursday U.S. stocks were mixed as Nasdaq fell over 3%, while Motorola Solutions and other companies surged on strong earnings and raised guidance.
benzinga.com Vericel Q3 2026 Earnings Call Transcript Vericel (NASDAQ:VCEL) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
benzinga.com Vericel Q3 EPS $0.27 Beats $0.06 Estimate, Sales $85.371M Beat $77.948M Estimate Vericel (NASDAQ:VCEL) reported quarterly earnings of $0.27 per share which beat the analyst consensus estimate of $0.06 by 350 percent. This is a 170 percent increase over earnings of $0.10 per share…- benzinga.com Vericel Raises FY2026 Sales Guidance from $330.000M-$340.000M to $344.000M-$346.000M vs $336.224M Est Vericel (NASDAQ:VCEL) raises FY2026 sales outlook from $330.000 million-$340.000 million to $344.000 million-$346.000 million vs $336.224 million estimate.
globenewswire.com Vericel Reports Third Quarter 2026 Financial Results and Raises Full-Year Financial Guidance Total Revenue Growth of 26% to $85.4 Million Net Income Increased 179% to $14.2 Million Adjusted EBITDA Margin of 30% Raised Full-Year Revenue Guidance to $344 to $346 Million and Adjusted EBITDA…
defenseworld.net Alkermes (NASDAQ:ALKS) vs. Vericel (NASDAQ:VCEL) Head to Head Contrast Vericel (NASDAQ: VCEL - Get Free Report) and Alkermes (NASDAQ: ALKS - Get Free Report) are both mid-cap healthcare companies, but which is the superior stock? We will compare the two companies based…
defenseworld.net Comparing Vericel (NASDAQ:VCEL) and Zymeworks (NASDAQ:ZYME) Zymeworks (NASDAQ: ZYME - Get Free Report) and Vericel (NASDAQ: VCEL - Get Free Report) are both mid-cap healthcare companies, but which is the better stock? We will contrast the two companies based…
benzinga.com Truist Securities Maintains Buy on Vericel, Lowers Price Target to $52 Truist Securities analyst Richard Newitter maintains Vericel (NASDAQ:VCEL) with a Buy and lowers the price target from $58 to $52.
benzinga.com TD Cowen Maintains Buy on Vericel, Raises Price Target to $58 TD Cowen analyst Joshua Jennings maintains Vericel (NASDAQ:VCEL) with a Buy and raises the price target from $55 to $58.
benzinga.com Truist Securities Reiterates Buy on Vericel, Raises Price Target to $58 Truist Securities analyst Richard Newitter reiterates Vericel (NASDAQ:VCEL) with a Buy and raises the price target from $54 to $58.
benzinga.com HC Wainwright & Co. Maintains Buy on Vericel, Raises Price Target to $72 HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Vericel (NASDAQ:VCEL) with a Buy and raises the price target from $70 to $72.- benzinga.com Vericel Q2 EPS $0.04 Beats $(0.03) Estimate, Sales $77.457M Beat $72.689M Estimate Vericel (NASDAQ:VCEL) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $(0.03) by 233.33 percent. This is a 500 percent increase over losses of $(0.01) per…
benzinga.com Vericel Raises FY2026 Sales Guidance from $326.000M-$336.000M to $330.000M-$340.000M vs $332.199M Est Vericel (NASDAQ:VCEL) raises FY2026 sales outlook from $326.000 million-$336.000 million to $330.000 million-$340.000 million vs $332.199 million estimate.- benzinga.com HC Wainwright & Co. Reiterates Buy on Vericel, Maintains $70 Price Target HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Vericel (NASDAQ:VCEL) with a Buy and maintains $70 price target.
benzinga.com Truist Securities Maintains Buy on Vericel, Raises Price Target to $54 Truist Securities analyst Richard Newitter maintains Vericel (NASDAQ:VCEL) with a Buy and raises the price target from $42 to $54.- benzinga.com HC Wainwright & Co. Maintains Buy on Vericel, Raises Price Target to $70 HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Vericel (NASDAQ:VCEL) with a Buy and raises the price target from $64 to $70.
- benzinga.com Vericel Raises FY2026 Sales Guidance from $316.000M-$326.000M to $326.000M-$336.000M vs $323.377M Est Vericel (NASDAQ:VCEL) raises FY2026 sales outlook from $316.000 million-$326.000 million to $326.000 million-$336.000 million vs $323.377 million estimate.
- benzinga.com Vericel Q1 EPS $(0.12) Beats $(0.15) Estimate, Sales $68.425M Beat $63.638M Estimate Vericel (NASDAQ:VCEL) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.15) by 20 percent. This is a 47.83 percent increase over losses of $(0.23) per…
- benzinga.com Truist Securities Maintains Buy on Vericel, Lowers Price Target to $42 Truist Securities analyst Richard Newitter maintains Vericel (NASDAQ:VCEL) with a Buy and lowers the price target from $48 to $42.
benzinga.com Vericel Corp. Awarded $196.8M HHS BARDA Contract For NonSurgical Debridement, Research And Development In Biotechnology (Except Nanobiotechnology) https://sam.gov/opp/f339ca12b7e047cdac559fe926d1a190/view- benzinga.com HC Wainwright & Co. Maintains Buy on Vericel, Raises Price Target to $64 HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Vericel (NASDAQ:VCEL) with a Buy and raises the price target from $60 to $64.
- benzinga.com Vericel Sees FY2026 Sales $316.000M-$326.000M vs $325.310M Est 2026 Financial GuidanceTotal revenue of $316 to $326 millionMACI revenue of $280 to $286 millionGross margin of approximately 75%Adjusted EBITDA margin of approximately 27%
- benzinga.com Vericel Q4 EPS $0.45 Beats $0.39 Estimate, Sales $92.918M Beat $91.122M Estimate Vericel (NASDAQ:VCEL) reported quarterly earnings of $0.45 per share which beat the analyst consensus estimate of $0.39 by 15.38 percent. This is a 18.42 percent increase over earnings of $0.38 per…
benzinga.com Earnings Breakdown: Vericel Q4 
benzinga.com Earnings Scheduled For February 26, 2026 
benzinga.com Why Is Vericel Stock Gaining Tuesday? Vericel Corporation (NASDAQ: VCEL) stock rose on Tuesday after announcing preliminary financial results for 2025.- benzinga.com Truist Securities Maintains Buy on Vericel, Lowers Price Target to $45 Truist Securities analyst Richard Newitter maintains Vericel (NASDAQ:VCEL) with a Buy and lowers the price target from $50 to $45.
- benzinga.com Truist Securities Reiterates Buy on Vericel, Raises Price Target to $50 Truist Securities analyst Richard Newitter reiterates Vericel (NASDAQ:VCEL) with a Buy and raises the price target from $41 to $50.
benzinga.com Earnings Scheduled For November 6, 2025 
benzinga.com This FedEx Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - benzinga.com Earnings Scheduled For July 31, 2025
- benzinga.com Earnings Scheduled For May 8, 2025
- benzinga.com Earnings Scheduled For February 27, 2025
- benzinga.com Earnings Scheduled For February 29, 2024 Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.
- benzinga.com Earnings Scheduled For November 8, 2023 Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its third quarter.
benzinga.com Earnings Scheduled For August 2, 2023 Companies Reporting Before The Bell • Vanguard Extended Duration Treasury ETF (NYSE:EDV) is estimated to report quarterly earnings at $0.37 per share on revenue of $784.53 million.- benzinga.com Earnings Scheduled For May 10, 2023 Companies Reporting Before The Bell • Nomad Foods (NYSE:NOMD) is projected to report quarterly earnings at $0.42 per share on revenue of $851.81 million.
- benzinga.com Earnings Scheduled For February 23, 2023 Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter.
- benzinga.com Earnings Scheduled For November 9, 2022 Companies Reporting Before The Bell • GCM Grosvenor (NASDAQ:GCMG) is likely to report quarterly earnings at $0.11 per share on revenue of $103.46 million.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 400 companies set new 52-week lows.
- benzinga.com Earnings Scheduled For August 3, 2022 Companies Reporting Before The Bell • Fresh Del Monte Produce (NYSE:FDP) is likely to report quarterly earnings at $0.79 per share on revenue of $1.15 billion.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 951 companies hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 1043 companies hit new 52-week lows.
- benzinga.com Earnings Scheduled For May 4, 2022 Companies Reporting Before The Bell • Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.
- benzinga.com The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data Here's a roundup of top developments in the biotech space over the last 24 hours:
- benzinga.com Earnings Scheduled For November 9, 2021 Companies Reporting Before The Bell • Imara (NASDAQ:IMRA) is projected to report earnings for its third quarter. • KT (NYSE:KT) is projected to report earnings for its third quarter.